Dominic Muston

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Decision Making

Top Venues

Applied health economics and health policy

Targeted oncology

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Dominic Muston
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit. Applied health economics and health policy (2024)
Dominic Muston
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit. Applied health economics and health policy 22 (5) (2024)
Dominic Muston
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit. Applied health economics and health policy 22 (5) (2024)
David Elsea, Dominic Muston, Lin Fan, Adela Mihai, Yang Meng, Adam Kasle, Matthew Monberg
Cost-Effectiveness Analysis of Biomarker Testing to Guide First-Line PARP Inhibitor Maintenance for Patients with Advanced Ovarian Cancer After Response to First-Line Platinum Chemotherapy in the USA. Targeted oncology (2023)
Wei Gao, Dominic Muston, Matthew Monberg, Kimmie McLaurin, Robert Hettle, Elizabeth Szamreta, Elyse Swallow, Su Zhang, Iden Kalemaj, James Signorovitch, R Brett McQueen
A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer. PharmacoEconomics 38 (11) (2021)